Results 191 to 200 of about 47,567 (220)

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Ca-A Cancer Journal for Clinicians, 2016
Lauren R Teras, Christopher R Flowers, James R Cerhan   +2 more
exaly  

Human medicines European public assessment report (EPAR): Ivozall, clofarabine, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 14/11/2019, Status: Authorised

Case Medical Research, 2019
openaire   +2 more sources

Improving Outcomes for Patients With Diffuse Large B-Cell Lymphoma

Ca-A Cancer Journal for Clinicians, 2010
Julie M Vose
exaly  

Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia

Leukemia and Lymphoma, 2020
Wei Guan, Liping Dou, Li Yu
exaly  

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish P Shanbhag, Richard F Ambinder
exaly  

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

Ca-A Cancer Journal for Clinicians, 2016
Markus Raderer, Barbara Kiesewetter, Andrés José Maria Ferreri   +2 more
exaly  

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 23/11/2015, Revision: 9, Status: Authorised

Case Medical Research, 2019
openaire   +2 more sources

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

New England Journal of Medicine, 2018
Shannon L Maude, Theodore W Laetsch, Jochen Buechner   +2 more
exaly  

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

New England Journal of Medicine, 2018
Jae H Park, Isabelle, Mithat Gönen
exaly  

Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 14/01/2016, Revision: 7, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source